Gene Therapy Gains Boost With $690M Collaboration April 4, 2007 By Nuala Moran LONDON - Big pharma has publicly embraced gene therapy for the first time, with the signing of a $690 million deal between Sanofi-Aventis SA and Oxford BioMedica plc for TroVax. (BioWorld International)Read More
RSS